Eisai Launches Antiasthmatic, Antitussive and Expectorant, ASTHPHYLLIN(R) S Tablets
Advertisement
Eisai Co., Ltd. announced that the Company launched ASTHPHYLLIN(R) S, a consumer health care medication to alleviate asthma, coughing and expectoration of sputum.
ASTHPHYLLIN(R) S is an OTC (over-the-counter) version of ASTHPHYLLIN(R), an antiasthmatic drug for prescription use and has been developed to fit the Japanese non-prescription drug approval standards for its therapeutic category.
ASTHPHYLLIN(R) S contains diprophylline and dl-methylephedrine hydrochloride to dilate constricted bronchial tubes and widen airways, making it easier to expectorate, in addition to noscapine which acts on the part of the central nervous system responsible for coughing, and diphenhydramine hydrochloride to relieve allergic asthma and coughing. These ingredients work together and can control coughing triggered by allergic inflammation in the mucous membranes of the respiratory tract, which is a key factor in asthma, and the nighttime coughing which is characteristic of the disease.
Most read news
Topics
Organizations
Other news from the department research and development
These products might interest you
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Chiron Delivers FLUVIRIN(R) Influenza Virus Vaccine to U.S. Customer - First Shipments Mark Beginning of 2005-2006 FLUVIRIN Supply
Researchers Succeed in Realizing a New Material Class - Metafluids for Transformation Acoustics
Generalized_epilepsy_with_febrile_seizures_plus
UCB Obtains European Antitrust Clearance for Take-Over of SCHWARZ PHARMA
W. C. Heraeus Becomes Majority Shareholder of Vadnais Technologies Corporation
SuppreMol launched as a new company
New compounding line for Altuglas International at its Bristol facility (Pennsylvania)
ACCELRYS ANNOUNCES TOPKAT UPDATE FOR HIGH THROUGHPUT TOXICITY PROFILING
A plastic that remembers - Bayer MaterialScience and BAM Federal Institute for Materials Research and Testing develop shape memory polymer from thermoplastic polyurethane